Sanofi-GSK's Next-Gen COVID-19 Booster Shows Potential Against Variants Of Concern

Sanofi SA (NASDAQ: SNY) said the next-gen COVID-19 vaccine candidate it has developed with GSK Plc (NASDAQ: GSK) in two trials showed a potential to protect against the virus's main variants of concern when used as a booster.